The board of directors of Lansen Pharmaceutical Holdings Limited announced that Mr. Stephen Burnau Hunt, after having served on the Board for 12 years, has retired as a Non-executive Director and a member of the Remuneration Committee of the Company with effect from 9 April 2022. Mr. Hunt has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company. The Chairman and the Board express their sincere gratitude to Mr. Hunt for his service and valuable contribution made to the Company.